22.07.20 ijBio Portfolio

Pharm Involved.

$1,000,000 on 12.06.20 Changes for 22.07.20:

AstraZeneca (AZN) $51,3 $57 (+11.1%) $111,100

Inovio (INO) $13,2 $26,2 (+98.5%) $198,500

Moderna (MRNA) $61,5 $83,2 (+35.3%) $135,300

Abbot (ABT) $88,5 $100,2 (+13.2%) $113,200

Gilead (GILD) $72,5 $76,2 (+5.1%) $105,100

Adaptive (ADPT) $42,2 $38,2 (-9.5%) $90,500

CytoDyn (CYDY) $3,12 $5,6 (+79.5%) $179,500

AbbVie (ABBV) $92,2 $97,7 (+6%) $106,000

Arcus (RCUS) $27,3 $23,5 (-13.9%) $86,100

Sorrento (SRNE) $4,6  $8,06 (+75.2%) $175,200

At close 22.07.20 = $1,300,500 (-1%)

per million dollars at 10% per share.

previous days

At close 21.07.20 = $1,314,300 (-1.9%)

At close 20.07.20 = $1,340,000 (+1.76%)

during the week 10-17.06.2020: +7.6%

for a month from June 12: +22,5%

during the week 03-10.06.2020: +0.5%

during the week 26-03.06.2020: -4.5%

during the week 19-26.06.2020:+21%

during the week 12-19.06 +5,5%

12.06.20 = $1,000,000

Global Communication Platforms Portfoilio

--

Portfolio News:

Moderna’s Vaccine Will Likely Be Approved, Analyst Says. Why the Stock Is ‘Unattractive.’

Should Inovio Be On Your Buy List As It Tackles A Coronavirus Vaccine?

Abbott Receives FDA Approval for iOS-Compatible App Allowing People Living With Chronic Pain and Movement Disorders to Personalize Therapy Via Their Mobile Device

Earnings Estimates Moving Higher for Sorrento Therapeutics (SRNE): Time to Buy?

There is a ‘ridiculous amount of speculation’ over coronavirus vaccine stocks: biotech analys

Better Coronavirus Stock: AstraZeneca vs. Moderna

CLASS ACTION UPDATE for TUFN, SRNE and CLNY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Sorrento Therapeutics, Inc. and Encourages Investors to Contact the Firm

SRNE ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 27, 2020 in the Class Action Filed on Behalf of Sorrento Therapeutics, Inc. Limited Shareholders

Astrazeneca (AZN) Stock Sinks As Market Gains: What You Should Know

Biotech ETFs to Gain on Coronavirus Vaccine Progress

5-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Sorrento Therapeutics, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

Trump: COVID-19 will get worse before it gets better

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Sorrento Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 27, 2020 - SRNE

U.S. to pay Pfizer, BioNTech $1.95B for 100M doses of COVID-19 vaccine

Pfizer’s Covid Vaccine Contract Spurs ‘Extreme’ Drugmaker Gains

SRNE Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Sorrento Therapeutics, Inc Shareholders With Losses Exceeding $250K of Class Action and Lead Plaintiff Deadline: July 27, 2020

A $2 Billion Bet on Pfizer’s Covid Vaccine Is Worth It

Coronavirus update: Pfizer strikes covid vaccine deal with US as Trump issues dire warning

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SRNE, WFC and JCOM

Infojet Club

With help but without the assistance of Yahoo Finance

Advertise With Us